Intervention Protocol

Haemodialysis duration, frequency and intensity for end-stage kidney disease

  1. Bin Zhu1,2,
  2. Min Jun1,
  3. Meg J Jardine3,
  4. Yong Jun Wang2,
  5. Vlado Perkovic1,*

Editorial Group: Cochrane Renal Group

Published Online: 12 SEP 2012

DOI: 10.1002/14651858.CD010064


How to Cite

Zhu B, Jun M, Jardine MJ, Wang YJ, Perkovic V. Haemodialysis duration, frequency and intensity for end-stage kidney disease (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD010064. DOI: 10.1002/14651858.CD010064.

Author Information

  1. 1

    The George Institute for Global Health, Renal and Metabolic Division, Camperdown, 2050, Australia

  2. 2

    Hangzhou Hospital of Traditional Chinese Medicine, Department of Nephrology, Hangzhou, Zhejiang, China

  3. 3

    Concord Repatriation General Hospital, Department of Renal Medicine, Concord, NSW, Australia

*Vlado Perkovic, Renal and Metabolic Division, The George Institute for Global Health, Level 10, King George V Building, 83-117 Missenden Rd, Camperdown, 2050, NSW, Australia. vperkovic@georgeinstitute.org.au.

Publication History

  1. Publication Status: New
  2. Published Online: 12 SEP 2012

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess whether an increase in the dose of haemodialysis (intensity, timing) improves mortality and other important clinical outcomes in people with ESKD who need maintenance dialysis.